{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:02:37Z","timestamp":1789376557301,"version":"build-2803163510"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"DOI":"10.1007\/s00011-026-02358-8","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T08:05:45Z","timestamp":1789373145000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Autoimmune processes and production of catalytically active antibodies-abzymes in prone to amyotrophic lateral sclerosis FUS(1-359) mice"],"prefix":"10.1007","volume":"75","author":[{"given":"Andrey E.","family":"Urusov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina A.","family":"Gorobets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kseniya S.","family":"Aulova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Timofeeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludmila B.","family":"Toporkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina A.","family":"Orlovskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksey A.","family":"Ustyugov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgy A.","family":"Nevinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"issue":"5\u20136","key":"2358_CR1","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1080\/21678421.2021.2023190","volume":"23","author":"P Mehta","year":"2022","unstructured":"Mehta P, Raymond J, Punjani R, Larson T, Han M, Bove F, Horton DK. Incidence of amyotrophic lateral sclerosis in the United States, 2014\u20132016. Amyotroph Lateral Scler Frontotemporal Degener. 2022;23(5\u20136):378\u201382. https:\/\/doi.org\/10.1080\/21678421.2021.2023190.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"46","key":"2358_CR2","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.15585\/mmwr.mm6746a1","volume":"67","author":"P Mehta","year":"2018","unstructured":"Mehta P, Kaye W, Raymond J, Punjani R, Larson T, Cohen J, Muravov O, Horton K. Prevalence of amyotrophic lateral sclerosis - United States, 2015. MMWR Morb Mortal Wkly Rep. 2018;67(46):1285\u20139. https:\/\/doi.org\/10.15585\/mmwr.mm6746a1.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"2358_CR3","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/WCO.0000000000000730","volume":"32","author":"E Longinetti","year":"2019","unstructured":"Longinetti E, Fang F. Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol. 2019;32(5):771\u20136. https:\/\/doi.org\/10.1097\/WCO.0000000000000730.","journal-title":"Curr Opin Neurol"},{"issue":"11","key":"2358_CR4","doi-asserted-by":"publisher","first-page":"e01131","DOI":"10.1002\/brb3.1131","volume":"8","author":"S Zhou","year":"2018","unstructured":"Zhou S, Zhou Y, Qian S, Chang W, Wang L, Fan D. Amyotrophic lateral sclerosis in Beijing: epidemiologic features and prognosis from 2010 to 2015. Brain Behav. 2018;8(11):e01131. https:\/\/doi.org\/10.1002\/brb3.1131.","journal-title":"Brain Behav"},{"issue":"4","key":"2358_CR5","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1136\/jnnp-2018-318974","volume":"90","author":"KY Jun","year":"2019","unstructured":"Jun KY, Park J, Oh KW, Kim EM, Bae JS, Kim I, Kim SH. Epidemiology of ALS in Korea using nationwide big data. J Neurol Neurosurg Psychiatry. 2019;90(4):395\u2013403. https:\/\/doi.org\/10.1136\/jnnp-2018-318974.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2358_CR6","doi-asserted-by":"publisher","unstructured":"Dugger BN, Dickson DW. Pathology of neurodegenerative diseases. Cold Spring Harb Perspect Biol. 2017;9(7). https:\/\/doi.org\/10.1101\/cshperspect.a028035.","DOI":"10.1101\/cshperspect.a028035"},{"key":"2358_CR7","doi-asserted-by":"crossref","unstructured":"Nevinsky GA. Autoimmune processes in multiple sclerosis: production of harmful catalytic antibodies associated with significant changes in the hematopoietic stem cell differentiation and proliferation. Trending Topics in Multiple Sclerosis. IntechOpen; 2016.","DOI":"10.5772\/63824"},{"key":"2358_CR8","doi-asserted-by":"crossref","unstructured":"Nevinsky GA. (2010) Natural catalytic antibodies in norm and in autoimmune diseases.","DOI":"10.1100\/tsw.2010.98"},{"key":"2358_CR9","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1100\/tsw.2010.98","volume":"10","author":"GA Nevinsky","year":"2010","unstructured":"Nevinsky GA, Buneva VN. Natural catalytic antibodies in norm, autoimmune, viral, and bacterial diseases. ScientificWorldJournal. 2010;10:1203\u201333. https:\/\/doi.org\/10.1100\/tsw.2010.98.","journal-title":"ScientificWorldJournal"},{"key":"2358_CR10","first-page":"1","volume-title":"Advances in Medicine and Biology","author":"GA Nevinsky","year":"2021","unstructured":"Nevinsky GA. The extreme diversity of autoantibodies and abzymes against different antigens in patients with various autoimmune diseases. In: Berhardt LV, editor. Advances in Medicine and Biology. Volume 184. New York, NY, USA: Nova Science Publishers, Inc.; 2021. pp. 1\u2013130."},{"key":"2358_CR11","doi-asserted-by":"publisher","DOI":"10.5772\/67790","volume-title":"Lupus","author":"G Nevinsky","year":"2017","unstructured":"Nevinsky G. Catalytic Antibodies in norm and systemic Lupus Erythematosus. In: Khan WA, editor. Lupus. London: IntechOpen; 2017. https:\/\/doi.org\/10.5772\/67790."},{"issue":"3","key":"2358_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.5812\/kmp.iranjradiol.17351065.3138","volume":"8","author":"MH Harirchian","year":"2011","unstructured":"Harirchian MH, Saberi H, Najafizadeh SR, Hashemi SA. Evaluation of brain and cervical MRI abnormality rates in patients with systemic lupus erythematosus with or without neurological manifestations. Iran J Radiol. 2011;8(3):157\u201360. https:\/\/doi.org\/10.5812\/kmp.iranjradiol.17351065.3138.","journal-title":"Iran J Radiol"},{"issue":"7","key":"2358_CR13","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1177\/0961203318763533","volume":"27","author":"B Cannerfelt","year":"2018","unstructured":"Cannerfelt B, Nystedt J, Jonsen A, Latt J, van Westen D, Lilja A, Bengtsson A, Nilsson P, Martensson J, Sundgren PC. White matter lesions and brain atrophy in systemic lupus erythematosus patients: correlation to cognitive dysfunction in a cohort of systemic lupus erythematosus patients using different definition models for neuropsychiatric systemic lupus erythematosus. Lupus. 2018;27(7):1140\u20139. https:\/\/doi.org\/10.1177\/0961203318763533.","journal-title":"Lupus"},{"issue":"10","key":"2358_CR14","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1177\/0961203318781004","volume":"27","author":"A Kalinowska-Lyszczarz","year":"2018","unstructured":"Kalinowska-Lyszczarz A, Pawlak MA, Pietrzak A, Pawlak-Bus K, Leszczynski P, Puszczewicz M, Paprzycki W, Kozubski W, Michalak S. Distinct regional brain atrophy pattern in multiple sclerosis and neuropsychiatric systemic lupus erythematosus patients. Lupus. 2018;27(10):1624\u201335. https:\/\/doi.org\/10.1177\/0961203318781004.","journal-title":"Lupus"},{"issue":"2","key":"2358_CR15","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/1352458512450352","volume":"19","author":"S Muller","year":"2013","unstructured":"Muller S, Saur R, Greve B, Melms A, Hautzinger M, Fallgatter AJ, Leyhe T. Similar autobiographical memory impairment in long-term secondary progressive multiple sclerosis and Alzheimer\u2019s disease. Mult Scler. 2013;19(2):225\u201332. https:\/\/doi.org\/10.1177\/1352458512450352.","journal-title":"Mult Scler"},{"issue":"9","key":"2358_CR16","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1001\/jamaneurol.2019.1534","volume":"76","author":"C Bridel","year":"2019","unstructured":"Bridel C, van Wieringen WN, Zetterberg H, Tijms BM, Teunissen CE, Alvarez-Cermeno theNFLG, Andreasson JC, Axelsson U, Backstrom M, Bartos DC, Bjerke A, Blennow M, Boxer K, Brundin A, Burman L, Christensen J, Fialova T, Forsgren L, Frederiksen L, Gisslen JL, Gray M, Gunnarsson E, Hall M, Hansson S, Herbert O, Jakobsson MK, Jessen-Krut J, Janelidze J, Johannsson S, Jonsson G, Kappos M, Khademi L, Khalil M, Kuhle M, Landen J, Leinonen M, Logroscino V, Lu G, Lycke CH, Magdalinou J, Malaspina NK, Mattsson A, Meeter N, Mehta LH, Modvig SR, Olsson S, Paterson T, Perez-Santiago RW, Piehl J, Pijnenburg F, Pyykko YAL, Ragnarsson OT, Rojas O, Romme Christensen JC, Sandberg J, Scherling L, Schott CS, Sellebjerg JM, Simone FT, Skillback IL, Stilund T, Sundstrom M, Svenningsson P, Tortelli A, Tortorella R, Trentini C, Troiano A, Turner M, van Swieten MR, Vagberg JC, Verbeek M, Villar MM, Visser LM, Wallin PJ, Weiss A, Wikkelso A, Wild C EJ. Diagnostic Value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis. JAMA Neurol. 2019;76(9):1035\u201348. https:\/\/doi.org\/10.1001\/jamaneurol.2019.1534.","journal-title":"JAMA Neurol"},{"key":"2358_CR17","doi-asserted-by":"publisher","unstructured":"Rauskolb S, Dombert B, Sendtner M. Insulin-like growth factor 1 in diabetic neuropathy and amyotrophic lateral sclerosis. Neurobiol Dis 97 (Pt B). 2017;103\u201313. https:\/\/doi.org\/10.1016\/j.nbd.2016.04.007.","DOI":"10.1016\/j.nbd.2016.04.007"},{"key":"2358_CR18","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/0968-0004(87)90208-8","volume":"12","author":"RA Lerner","year":"1987","unstructured":"Lerner RA, Tramontano A. Antibodies as enzymes. Trends Biochem Sci. 1987;12:427\u201330. https:\/\/doi.org\/10.1016\/0968-0004(87)90208-8.","journal-title":"Trends Biochem Sci"},{"issue":"2\u20133","key":"2358_CR19","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3109\/08830189309061698","volume":"10","author":"JD Stewart","year":"1993","unstructured":"Stewart JD, Benkovic SJ. Recent developments in catalytic antibodies. Int Rev Immunol. 1993;10(2\u20133):229\u201340. https:\/\/doi.org\/10.3109\/08830189309061698.","journal-title":"Int Rev Immunol"},{"issue":"12","key":"2358_CR20","doi-asserted-by":"publisher","first-page":"M24","DOI":"10.1016\/S0962-8924(99)01682-7","volume":"9","author":"AB Martin","year":"1999","unstructured":"Martin AB, Schultz PG. Opportunities at the interface of chemistry and biology. Trends Cell Biol. 1999;9(12):M24\u201328.","journal-title":"Trends Cell Biol"},{"key":"2358_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000058794","volume":"77","author":"A Tramontano","year":"2000","unstructured":"Tramontano A, Gololobov G, Paul S. Proteolytic antibodies: origins, selection and induction. Chem Immunol. 2000;77:1\u201317. https:\/\/doi.org\/10.1159\/000058794.","journal-title":"Chem Immunol"},{"issue":"2","key":"2358_CR22","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1007\/s12010-022-04183-1","volume":"195","author":"D Zhao","year":"2023","unstructured":"Zhao D, Chen J, Hu X, Zhang S. Catalytic antibodies: design, expression, and their applications in medicine. Appl Biochem Biotechnol. 2023;195(2):1514\u201340. https:\/\/doi.org\/10.1007\/s12010-022-04183-1.","journal-title":"Appl Biochem Biotechnol"},{"issue":"1\u20132","key":"2358_CR23","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/s0022-1759(02)00228-4","volume":"269","author":"EL Ostler","year":"2002","unstructured":"Ostler EL, Resmini M, Brocklehurst K, Gallacher G. Polyclonal catalytic antibodies. J Immunol Methods. 2002;269(1\u20132):111\u201324. https:\/\/doi.org\/10.1016\/s0022-1759(02)00228-4.","journal-title":"J Immunol Methods"},{"issue":"7","key":"2358_CR24","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1007\/s10529-014-1503-8","volume":"36","author":"S Padiolleau-Lefevre","year":"2014","unstructured":"Padiolleau-Lefevre S, Ben Naya R, Shahsavarian MA, Friboulet A, Avalle B. Catalytic antibodies and their applications in biotechnology: state of the art. Biotechnol Lett. 2014;36(7):1369\u201379. https:\/\/doi.org\/10.1007\/s10529-014-1503-8.","journal-title":"Biotechnol Lett"},{"issue":"6","key":"2358_CR25","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.copbio.2005.10.003","volume":"16","author":"CV Hanson","year":"2005","unstructured":"Hanson CV, Nishiyama Y, Paul S. Catalytic antibodies and their applications. Curr Opin Biotechnol. 2005;16(6):631\u20136. https:\/\/doi.org\/10.1016\/j.copbio.2005.10.003.","journal-title":"Curr Opin Biotechnol"},{"issue":"3","key":"2358_CR26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/BF02900358","volume":"5","author":"S Paul","year":"1996","unstructured":"Paul S. Natural catalytic antibodies. Mol Biotechnol. 1996;5(3):197\u2013207. https:\/\/doi.org\/10.1007\/BF02900358.","journal-title":"Mol Biotechnol"},{"issue":"5","key":"2358_CR27","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.it.2020.03.006","volume":"41","author":"JD Dimitrov","year":"2020","unstructured":"Dimitrov JD, Lacroix-Desmazes S. Noncanonical functions of antibodies. Trends Immunol. 2020;41(5):379\u201393. https:\/\/doi.org\/10.1016\/j.it.2020.03.006.","journal-title":"Trends Immunol"},{"issue":"2","key":"2358_CR28","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jaut.2011.05.007","volume":"37","author":"B Wootla","year":"2011","unstructured":"Wootla B, Lacroix-Desmazes S, Warrington AE, Bieber AJ, Kaveri SV, Rodriguez M. Autoantibodies with enzymatic properties in human autoimmune diseases. J Autoimmun. 2011;37(2):144\u201350. https:\/\/doi.org\/10.1016\/j.jaut.2011.05.007.","journal-title":"J Autoimmun"},{"issue":"6","key":"2358_CR29","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/jmr.1035","volume":"23","author":"AS Kamalanathan","year":"2010","unstructured":"Kamalanathan AS, Goulvestre C, Weill B, Vijayalakshmi MA. Proteolysis activity of IgM antibodies from rheumatoid arthritis patients\u2019 sera: evidence of atypical catalytic site. J Mol Recognit. 2010;23(6):577\u201382. https:\/\/doi.org\/10.1002\/jmr.1035.","journal-title":"J Mol Recognit"},{"issue":"5","key":"2358_CR30","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.autrev.2006.01.004","volume":"5","author":"AG Gabibov","year":"2006","unstructured":"Gabibov AG, Ponomarenko NA, Tretyak EB, Paltsev MA, Suchkov SV. Catalytic autoantibodies in clinical autoimmunity and modern medicine. Autoimmun Rev. 2006;5(5):324\u201330. https:\/\/doi.org\/10.1016\/j.autrev.2006.01.004.","journal-title":"Autoimmun Rev"},{"issue":"4","key":"2358_CR31","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1080\/08916930902832009","volume":"42","author":"AV Kozyr","year":"2009","unstructured":"Kozyr AV, Gabibov AG. DNA-hydrolyzing Ab: is catalytic activity a clue for physiological significance? Autoimmunity. 2009;42(4):359\u201361. https:\/\/doi.org\/10.1080\/08916930902832009.","journal-title":"Autoimmunity"},{"issue":"1","key":"2358_CR32","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1021\/bi050675k","volume":"45","author":"NA Ponomarenko","year":"2006","unstructured":"Ponomarenko NA, Vorobiev II, Alexandrova ES, Reshetnyak AV, Telegin GB, Khaidukov SV, Avalle B, Karavanov A, Morse HC 3rd, Thomas D, Friboulet A, Gabibov AG. Induction of a protein-targeted catalytic response in autoimmune prone mice: antibody-mediated cleavage of HIV-1 glycoprotein GP120. Biochemistry. 2006;45(1):324\u201330. https:\/\/doi.org\/10.1021\/bi050675k.","journal-title":"Biochemistry"},{"issue":"11","key":"2358_CR33","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1002\/bies.200900020","volume":"31","author":"A Belogurov Jr","year":"2009","unstructured":"Belogurov A Jr., Kozyr A, Ponomarenko N, Gabibov A. Catalytic antibodies: balancing between Dr. Jekyll and Mr. Hyde Bioessays. 2009;31(11):1161\u201371. https:\/\/doi.org\/10.1002\/bies.200900020.","journal-title":"Hyde Bioessays"},{"issue":"2","key":"2358_CR34","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.bbadis.2010.06.010","volume":"1812","author":"AL Croxford","year":"2011","unstructured":"Croxford AL, Kurschus FC, Waisman A. Mouse models for multiple sclerosis: historical facts and future implications. Biochim Biophys Acta. 2011;1812(2):177\u201383. https:\/\/doi.org\/10.1016\/j.bbadis.2010.06.010.","journal-title":"Biochim Biophys Acta"},{"key":"2358_CR35","unstructured":"Catalytic antibodies. (2006). Wiley-VCH Verlag GmbH and Co. KgaA, Weinheim, Germany."},{"issue":"3","key":"2358_CR36","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/0165-2478(88)90043-0","volume":"17","author":"Y Shoenfeld","year":"1988","unstructured":"Shoenfeld Y, Ben-Yehuda O, Messinger Y, Bentwitch Z, Rauch J, Isenberg DI, Gadoth N. Autoimmune diseases other than lupus share common anti-DNA idiotypes. Immunol Lett. 1988;17(3):285\u201391. https:\/\/doi.org\/10.1016\/0165-2478(88)90043-0.","journal-title":"Immunol Lett"},{"issue":"16","key":"2358_CR37","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/0161-5890(93)90458-n","volume":"30","author":"A Berneman","year":"1993","unstructured":"Berneman A, Guilbert B, Eschrich S, Avrameas S. IgG auto- and polyreactivities of normal human sera. Mol Immunol. 1993;30(16):1499\u2013510. https:\/\/doi.org\/10.1016\/0161-5890(93)90458-n.","journal-title":"Mol Immunol"},{"issue":"6","key":"2358_CR38","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/0952-7915(95)80053-0","volume":"7","author":"A Coutinho","year":"1995","unstructured":"Coutinho A, Kazatchkine MD, Avrameas S. Natural autoantibodies. Curr Opin Immunol. 1995;7(6):812\u20138. https:\/\/doi.org\/10.1016\/0952-7915(95)80053-0.","journal-title":"Curr Opin Immunol"},{"issue":"4909","key":"2358_CR39","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1126\/science.2727702","volume":"244","author":"S Paul","year":"1989","unstructured":"Paul S, Volle DJ, Beach CM, Johnson DR, Powell MJ, Massey RJ. Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody. Science. 1989;244(4909):1158\u201362. https:\/\/doi.org\/10.1126\/science.2727702.","journal-title":"Science"},{"issue":"7","key":"2358_CR40","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.4049\/jimmunol.154.7.3328","volume":"154","author":"L Li","year":"1995","unstructured":"Li L, Paul S, Tyutyulkova S, Kazatchkine MD, Kaveri S. Catalytic activity of anti-thyroglobulin antibodies. J Immunol. 1995;154(7):3328\u201332.","journal-title":"J Immunol"},{"issue":"5","key":"2358_CR41","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.4049\/jimmunol.155.5.2695","volume":"155","author":"R Kalaga","year":"1995","unstructured":"Kalaga R, Li L, O\u2019Dell JR, Paul S. Unexpected presence of polyreactive catalytic antibodies in IgG from unimmunized donors and decreased levels in rheumatoid arthritis. J Immunol. 1995;155(5):2695\u2013702.","journal-title":"J Immunol"},{"key":"2358_CR42","first-page":"179","volume":"6","author":"AN Savel\u2019ev","year":"1999","unstructured":"Savel\u2019ev AN, Eneyskaya EV, Shabalin KA, Filatov MV, Neustroev KN. Autoantibodies with amylolytic activity. Protein Pept Lett. 1999;6:179\u201384.","journal-title":"Protein Pept Lett"},{"issue":"3","key":"2358_CR43","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/j.1582-4934.2007.00048.x","volume":"11","author":"AA Andryushkova","year":"2007","unstructured":"Andryushkova AA, Kuznetsova IA, Bineva VN, Toporkova LB, Sakhno LV, Tikhonova MA, Chernykh ER, Orlovskaya IA, Nevinsky GA. Formation of different abzymes in autoimmune-prone MRL-lpr\/lpr mice is associated with changes in colony formation of haematopoietic progenitors. J Cell Mol Med. 2007;11(3):531\u201351. https:\/\/doi.org\/10.1111\/j.1582-4934.2007.00048.x.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"2358_CR44","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/jcmm.12704","volume":"20","author":"VB Doronin","year":"2016","unstructured":"Doronin VB, Parkhomenko TA, Korablev A, Toporkova LB, Lopatnikova JA, Alshevskaja AA, Sennikov SV, Buneva VN, Budde T, Meuth SG, Orlovskaya IA, Popova NA, Nevinsky GA. Changes in different parameters, lymphocyte proliferation and hematopoietic progenitor colony formation in EAE mice treated with myelin oligodendrocyte glycoprotein. J Cell Mol Med. 2016;20(1):81\u201394. https:\/\/doi.org\/10.1111\/jcmm.12704.","journal-title":"J Cell Mol Med"},{"issue":"12","key":"2358_CR45","doi-asserted-by":"publisher","first-page":"5816","DOI":"10.1111\/jcmm.13850","volume":"22","author":"KS Aulova","year":"2018","unstructured":"Aulova KS, Toporkova LB, Lopatnikova JA, Alshevskaya AA, Sedykh SE, Buneva VN, Budde T, Meuth SG, Popova NA, Orlovskaya IA, Nevinsky GA. Changes in cell differentiation and proliferation lead to production of abzymes in EAE mice treated with DNA-Histone complexes. J Cell Mol Med. 2018;22(12):5816\u201332. https:\/\/doi.org\/10.1111\/jcmm.13850.","journal-title":"J Cell Mol Med"},{"key":"2358_CR46","doi-asserted-by":"publisher","unstructured":"Urusov AE, Aulova KS, Dmitrenok PS, Buneva VN, Nevinsky GA. Experimental autoimmune encephalomyelitis of mice: enzymatic cross site-specific hydrolysis of H4 histone by IgGs against histones and myelin basic protein. Int J Mol Sci. 2022;23(16). https:\/\/doi.org\/10.3390\/ijms23169182.","DOI":"10.3390\/ijms23169182"},{"key":"2358_CR47","doi-asserted-by":"publisher","unstructured":"Urusov AE, Aulova KS, Dmitrenok PS, Buneva VN, Nevinsky GA. EAE of mice: enzymatic cross site-specific hydrolysis of H2A histone by IgGs against H2A, H1, H2B, H3, and H4 histones and myelin basic protein. Int J Mol Sci. 2023;24(10). https:\/\/doi.org\/10.3390\/ijms24108636.","DOI":"10.3390\/ijms24108636"},{"key":"2358_CR48","doi-asserted-by":"publisher","unstructured":"Urusov AE, Aulova KS, Dmitrenok PS, Buneva VN, Nevinsky GA. EAE of mice: enzymatic cross site-specific hydrolysis of H2B histone by IgGs against H1, H2A, H2B, H3, and H4 histones and myelin basic protein. Molecules. 2023;28(7). https:\/\/doi.org\/10.3390\/molecules28072973.","DOI":"10.3390\/molecules28072973"},{"issue":"1","key":"2358_CR49","doi-asserted-by":"publisher","first-page":"33","DOI":"10.46439\/biomedres.4.035","volume":"4","author":"AE Urusov","year":"2023","unstructured":"Urusov AE, Aulova KS, Dmitrenok PS, Buneva VN, Nevinsky GA. Experimental autoimmune encephalomyelitis of mice: catalytic cross site-specific hydrolysis of H1 histone by IgG antibodies against H1, H2A, H2B, H3, H4 histones, and myelin basic protein. J Biomed Res. 2023;4(1):33\u201360.","journal-title":"J Biomed Res"},{"issue":"2","key":"2358_CR50","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s11033-020-06117-8","volume":"48","author":"KS Aulova","year":"2021","unstructured":"Aulova KS, Urusov AE, Toporkova LB, Sedykh SE, Shevchenko YA, Tereshchenko VP, Sennikov SV, Budde T, Meuth SG, Orlovskaya IA, Nevinsky GA. Catalytic antibodies in the bone marrow and other organs of Th mice during spontaneous development of experimental autoimmune encephalomyelitis associated with cell differentiation. Mol Biol Rep. 2021;48(2):1055\u201368. https:\/\/doi.org\/10.1007\/s11033-020-06117-8.","journal-title":"Mol Biol Rep"},{"key":"2358_CR51","doi-asserted-by":"publisher","unstructured":"Aulova KS, Urusov AE, Toporkova LB, Sedykh SE, Shevchenko JA, Tereshchenko VP, Sennikov SV, Orlovskaya IA, Nevinsky GA. Cell differentiation and proliferation in the bone marrow and other organs of 2D2 mice during spontaneous development of EAE leading to the production of abzymes. Molecules. 2022;27(7). https:\/\/doi.org\/10.3390\/molecules27072195.","DOI":"10.3390\/molecules27072195"},{"key":"2358_CR52","doi-asserted-by":"publisher","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","volume":"3","author":"O Hardiman","year":"2017","unstructured":"Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, Shaw PJ, Simmons Z, van den Berg LH. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3:17071. https:\/\/doi.org\/10.1038\/nrdp.2017.71.","journal-title":"Nat Rev Dis Primers"},{"key":"2358_CR53","doi-asserted-by":"publisher","first-page":"171","DOI":"10.4103\/2152-7806.169561","volume":"6","author":"S Zarei","year":"2015","unstructured":"Zarei S, Carr K, Reiley L, Diaz K, Guerra O, Altamirano PF, Pagani W, Lodin D, Orozco G, Chinea A. A comprehensive review of amyotrophic lateral sclerosis. Surg Neurol Int. 2015;6:171. https:\/\/doi.org\/10.4103\/2152-7806.169561.","journal-title":"Surg Neurol Int"},{"issue":"D1","key":"2358_CR54","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"MJ Landrum","year":"2018","unstructured":"Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipiralla S, Gu B, Hart J, Hoffman D, Jang W, Karapetyan K, Katz K, Liu C, Maddipatla Z, Malheiro A, McDaniel K, Ovetsky M, Riley G, Zhou G, Holmes JB, Kattman BL, Maglott DR. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46(D1):D1062\u20137. https:\/\/doi.org\/10.1093\/nar\/gkx1153.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"2358_CR55","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1097\/WCO.0000000000000737","volume":"32","author":"D Brenner","year":"2019","unstructured":"Brenner D, Weishaupt JH. Update on amyotrophic lateral sclerosis genetics. Curr Opin Neurol. 2019;32(5):735\u20139. https:\/\/doi.org\/10.1097\/WCO.0000000000000737.","journal-title":"Curr Opin Neurol"},{"key":"2358_CR56","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1750-1326-7-53","volume":"7","author":"C Verbeeck","year":"2012","unstructured":"Verbeeck C, Deng Q, Dejesus-Hernandez M, Taylor G, Ceballos-Diaz C, Kocerha J, Golde T, Das P, Rademakers R, Dickson DW, Kukar T. Expression of fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis. Mol Neurodegener. 2012;7:53. https:\/\/doi.org\/10.1186\/1750-1326-7-53.","journal-title":"Mol Neurodegener"},{"issue":"3","key":"2358_CR57","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1172\/JCI72723","volume":"124","author":"H Qiu","year":"2014","unstructured":"Qiu H, Lee S, Shang Y, Wang WY, Au KF, Kamiya S, Barmada SJ, Finkbeiner S, Lui H, Carlton CE, Tang AA, Oldham MC, Wang H, Shorter J, Filiano AJ, Roberson ED, Tourtellotte WG, Chen B, Tsai LH, Huang EJ. ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects. J Clin Invest. 2014;124(3):981\u201399. https:\/\/doi.org\/10.1172\/JCI72723.","journal-title":"J Clin Invest"},{"issue":"3","key":"2358_CR58","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1093\/hmg\/ddu494","volume":"24","author":"M Tibshirani","year":"2015","unstructured":"Tibshirani M, Tradewell ML, Mattina KR, Minotti S, Yang W, Zhou H, Strong MJ, Hayward LJ, Durham HD. Cytoplasmic sequestration of FUS\/TLS associated with ALS alters histone marks through loss of nuclear protein arginine methyltransferase 1. Hum Mol Genet. 2015;24(3):773\u201386. https:\/\/doi.org\/10.1093\/hmg\/ddu494.","journal-title":"Hum Mol Genet"},{"issue":"Pt 9","key":"2358_CR59","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1093\/brain\/aww161","volume":"139","author":"G Shiihashi","year":"2016","unstructured":"Shiihashi G, Ito D, Yagi T, Nihei Y, Ebine T, Suzuki N. Mislocated FUS is sufficient for gain-of-toxic-function amyotrophic lateral sclerosis phenotypes in mice. Brain. 2016;139(Pt 9):2380\u201394. https:\/\/doi.org\/10.1093\/brain\/aww161.","journal-title":"Brain"},{"issue":"5","key":"2358_CR60","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1093\/brain\/awaa076","volume":"143","author":"X Zhang","year":"2020","unstructured":"Zhang X, Wang F, Hu Y, Chen R, Meng D, Guo L, Lv H, Guan J, Jia Y. In vivo stress granule misprocessing evidenced in a FUS knock-in ALS mouse model. Brain. 2020;143(5):1350\u201367. https:\/\/doi.org\/10.1093\/brain\/awaa076.","journal-title":"Brain"},{"key":"2358_CR61","doi-asserted-by":"publisher","first-page":"10465","DOI":"10.1038\/ncomms10465","volume":"7","author":"A Sharma","year":"2016","unstructured":"Sharma A, Lyashchenko AK, Lu L, Nasrabady SE, Elmaleh M, Mendelsohn M, Nemes A, Tapia JC, Mentis GZ, Shneider NA. ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function. Nat Commun. 2016;7:10465. https:\/\/doi.org\/10.1038\/ncomms10465.","journal-title":"Nat Commun"},{"issue":"11","key":"2358_CR62","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1093\/brain\/awx248","volume":"140","author":"A Devoy","year":"2017","unstructured":"Devoy A, Kalmar B, Stewart M, Park H, Burke B, Noy SJ, Redhead Y, Humphrey J, Lo K, Jaeger J, Mejia Maza A, Sivakumar P, Bertolin C, Soraru G, Plagnol V, Greensmith L, Acevedo Arozena A, Isaacs AM, Davies B, Fratta P, Fisher EMC. Humanized mutant FUS drives progressive motor neuron degeneration without aggregation in \u2018FUSDelta14\u2019 knockin mice. Brain. 2017;140(11):2797\u2013805. https:\/\/doi.org\/10.1093\/brain\/awx248.","journal-title":"Brain"},{"issue":"4","key":"2358_CR63","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.neuron.2018.09.044","volume":"100","author":"J Lopez-Erauskin","year":"2018","unstructured":"Lopez-Erauskin J, Tadokoro T, Baughn MW, Myers B, McAlonis-Downes M, Chillon-Marinas C, Asiaban JN, Artates J, Bui AT, Vetto AP, Lee SK, Le AV, Sun Y, Jambeau M, Boubaker J, Swing D, Qiu J, Hicks GG, Ouyang Z, Fu XD, Tessarollo L, Ling SC, Parone PA, Shaw CE, Marsala M, Lagier-Tourenne C, Cleveland DW, Da Cruz S. ALS\/FTD-Linked Mutation in FUS suppresses intra-axonal protein synthesis and drives disease without nuclear loss-of-function of FUS. Neuron. 2018;100(4):816\u2013e830817. https:\/\/doi.org\/10.1016\/j.neuron.2018.09.044.","journal-title":"Neuron"},{"issue":"10","key":"2358_CR64","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.15252\/embj.201592559","volume":"35","author":"J Scekic-Zahirovic","year":"2016","unstructured":"Scekic-Zahirovic J, Sendscheid O, El Oussini H, Jambeau M, Sun Y, Mersmann S, Wagner M, Dieterle S, Sinniger J, Dirrig-Grosch S, Drenner K, Birling MC, Qiu J, Zhou Y, Li H, Fu XD, Rouaux C, Shelkovnikova T, Witting A, Ludolph AC, Kiefer F, Storkebaum E, Lagier-Tourenne C, Dupuis L. Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss. EMBO J. 2016;35(10):1077\u201397. https:\/\/doi.org\/10.15252\/embj.201592559.","journal-title":"EMBO J"},{"issue":"6","key":"2358_CR65","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00401-017-1687-9","volume":"133","author":"J Scekic-Zahirovic","year":"2017","unstructured":"Scekic-Zahirovic J, Oussini HE, Mersmann S, Drenner K, Wagner M, Sun Y, Allmeroth K, Dieterle S, Sinniger J, Dirrig-Grosch S, Rene F, Dormann D, Haass C, Ludolph AC, Lagier-Tourenne C, Storkebaum E, Dupuis L. Motor neuron intrinsic and extrinsic mechanisms contribute to the pathogenesis of FUS-associated amyotrophic lateral sclerosis. Acta Neuropathol. 2017;133(6):887\u2013906. https:\/\/doi.org\/10.1007\/s00401-017-1687-9.","journal-title":"Acta Neuropathol"},{"issue":"35","key":"2358_CR66","doi-asserted-by":"publisher","first-page":"25266","DOI":"10.1074\/jbc.M113.492017","volume":"288","author":"TA Shelkovnikova","year":"2013","unstructured":"Shelkovnikova TA, Peters OM, Deykin AV, Connor-Robson N, Robinson H, Ustyugov AA, Bachurin SO, Ermolkevich TG, Goldman IL, Sadchikova ER, Kovrazhkina EA, Skvortsova VI, Ling SC, Da Cruz S, Parone PA, Buchman VL, Ninkina NN. Fused in sarcoma (FUS) protein lacking nuclear localization signal (NLS) and major RNA binding motifs triggers proteinopathy and severe motor phenotype in transgenic mice. J Biol Chem. 2013;288(35):25266\u201374. https:\/\/doi.org\/10.1074\/jbc.M113.492017.","journal-title":"J Biol Chem"},{"issue":"3","key":"2358_CR67","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10048-018-0553-9","volume":"19","author":"SY Funikov","year":"2018","unstructured":"Funikov SY, Rezvykh AP, Mazin PV, Morozov AV, Maltsev AV, Chicheva MM, Vikhareva EA, Evgen\u2019ev MB, Ustyugov AA. FUS(1-359) transgenic mice as a model of ALS: pathophysiological and molecular aspects of the proteinopathy. Neurogenetics. 2018;19(3):189\u2013204. https:\/\/doi.org\/10.1007\/s10048-018-0553-9.","journal-title":"Neurogenetics"},{"issue":"Suppl 1","key":"2358_CR68","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1134\/S0006297924140037","volume":"89","author":"A Rezvykh","year":"2024","unstructured":"Rezvykh A, Shteinberg D, Bronovitsky E, Ustyugov A, Funikov S. Animal models of FUS-proteinopathy: a systematic review. Biochem (Mosc). 2024;89(Suppl 1):S34\u201356. https:\/\/doi.org\/10.1134\/S0006297924140037.","journal-title":"Biochem (Mosc)"},{"issue":"8","key":"2358_CR69","first-page":"513","volume":"153","author":"S Fournel","year":"2002","unstructured":"Fournel S, Muller S. Anti-nucleosome antibodies and T-cell response in systemic lupus erythematosus. Ann Med Interne (Paris). 2002;153(8):513\u20139.","journal-title":"Ann Med Interne (Paris)"},{"issue":"4","key":"2358_CR70","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1073\/pnas.98.4.1793","volume":"98","author":"RA Williamson","year":"2001","unstructured":"Williamson RA, Burgoon MP, Owens GP, Ghausi O, Leclerc E, Firme L, Carlson S, Corboy J, Parren PW, Sanna PP, Gilden DH, Burton DR. Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis. Proc Natl Acad Sci U S A. 2001;98(4):1793\u20138. https:\/\/doi.org\/10.1073\/pnas.98.4.1793.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"2358_CR71","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1002\/glia.24078","volume":"69","author":"TA van Wageningen","year":"2021","unstructured":"van Wageningen TA, Gerrits E, Palacin IBS, Huitinga I, Eggen BJL, van Dam AM. Exploring reported genes of microglia RNA-sequencing data: uses and considerations. Glia. 2021;69(12):2933\u201346. https:\/\/doi.org\/10.1002\/glia.24078.","journal-title":"Glia"},{"issue":"Pt 2","key":"2358_CR72","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/brain\/awp307","volume":"133","author":"JF Sumowski","year":"2010","unstructured":"Sumowski JF, Wylie GR, Deluca J, Chiaravalloti N. Intellectual enrichment is linked to cerebral efficiency in multiple sclerosis: functional magnetic resonance imaging evidence for cognitive reserve. Brain. 2010;133(Pt 2):362\u201374. https:\/\/doi.org\/10.1093\/brain\/awp307.","journal-title":"Brain"},{"key":"2358_CR73","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/978-1-4613-2970-1_7","volume-title":"Alkaline Phosphatase","author":"RB McComb","year":"1979","unstructured":"McComb RB, Bowers GN, Posen S. Measurement of alkaline phosphatase activity. In: McComb RB, Bowers GN, Posen S, editors. Alkaline Phosphatase. Boston, MA: Springer US; 1979. pp. 289\u2013372. https:\/\/doi.org\/10.1007\/978-1-4613-2970-1_7."},{"key":"2358_CR74","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/s0076-6879(84)05016-3","volume":"105","author":"H Aebi","year":"1984","unstructured":"Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121\u20136. https:\/\/doi.org\/10.1016\/s0076-6879(84)05016-3.","journal-title":"Methods Enzymol"},{"key":"2358_CR75","doi-asserted-by":"publisher","unstructured":"Urusov AE, Tolmacheva AS, Aulova KS, Nevinsky GA. Autoantibody-abzymes with catalase activity in experimental autoimmune encephalomyelitis mice. Molecules. 2023;28(3). https:\/\/doi.org\/10.3390\/molecules28031330.","DOI":"10.3390\/molecules28031330"},{"issue":"2","key":"2358_CR76","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s11302-005-5435-6","volume":"2","author":"JL Millan","year":"2006","unstructured":"Millan JL. Alkaline Phosphatases: Structure, substrate specificity and functional relatedness to other members of a large superfamily of enzymes. Purinergic Signal. 2006;2(2):335\u201341. https:\/\/doi.org\/10.1007\/s11302-005-5435-6.","journal-title":"Purinergic Signal"},{"issue":"5","key":"2358_CR77","first-page":"326","volume":"56","author":"L Tam\u00e1s","year":"2002","unstructured":"Tam\u00e1s L, Huttov\u00e1 J, Mistrk I, Kogan G. Effect of carboxymethyl chitin-glucan on the activity of some hydrolytic enzymes in maize plants. Chem Pap. 2002;56(5):326\u20139.","journal-title":"Chem Pap"},{"issue":"10","key":"2358_CR78","doi-asserted-by":"publisher","first-page":"485","DOI":"10.4155\/bio-2023-0207","volume":"16","author":"SU Pathan","year":"2024","unstructured":"Pathan SU, Kharwar A, Ibrahim MA, Singh SB, Bajaj P. Enzymes as indispensable markers in disease diagnosis. Bioanalysis. 2024;16(10):485\u201397. https:\/\/doi.org\/10.4155\/bio-2023-0207.","journal-title":"Bioanalysis"},{"key":"2358_CR79","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40697-015-0066-5","volume":"2","author":"SV Badve","year":"2015","unstructured":"Badve SV, Zhang L, Coombes JS, Pascoe EM, Cass A, Clarke P, Ferrari P, McDonald SP, Morrish AT, Pedagogos E, Perkovic V, Reidlinger D, Scaria A, Walker R, Vergara LA, Hawley CM, Johnson DW, Group HSC. Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial. Can J Kidney Health Dis. 2015;2:33. https:\/\/doi.org\/10.1186\/s40697-015-0066-5.","journal-title":"Can J Kidney Health Dis"},{"issue":"17","key":"2358_CR80","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1016\/j.febslet.2012.05.008","volume":"586","author":"F Sacco","year":"2012","unstructured":"Sacco F, Perfetto L, Castagnoli L, Cesareni G. The human phosphatase interactome: an intricate family portrait. FEBS Lett. 2012;586(17):2732\u20139. https:\/\/doi.org\/10.1016\/j.febslet.2012.05.008.","journal-title":"FEBS Lett"},{"key":"2358_CR81","unstructured":"PubChem E. Summary for Enzyme 3.1.3.1, Alkaline phosphatase (EC 3.1.3.1) (2004) National Library of Medicine (US), National Center for Biotechnology Information. https:\/\/pubchem.ncbi.nlm.nih.gov\/protein\/EC:3.1.3.1. Accessed 15 April, 2026."},{"key":"2358_CR82","doi-asserted-by":"publisher","unstructured":"Urusov AE, Aulova KS, Nevinsky GA. Autoantibodies-abzymes with phosphatase activity in experimental autoimmune encephalomyelitis mice. Molecules. 2024;29(6). https:\/\/doi.org\/10.3390\/molecules29061382.","DOI":"10.3390\/molecules29061382"},{"issue":"7","key":"2358_CR83","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s00018-013-1388-z","volume":"71","author":"S Janecek","year":"2014","unstructured":"Janecek S, Svensson B, MacGregor EA. alpha-Amylase: an enzyme specificity found in various families of glycoside hydrolases. Cell Mol Life Sci. 2014;71(7):1149\u201370. https:\/\/doi.org\/10.1007\/s00018-013-1388-z.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"2358_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10620-006-9589-z","volume":"52","author":"DC Whitcomb","year":"2007","unstructured":"Whitcomb DC, Lowe ME. Human pancreatic digestive enzymes. Dig Dis Sci. 2007;52(1):1\u201317. https:\/\/doi.org\/10.1007\/s10620-006-9589-z.","journal-title":"Dig Dis Sci"},{"issue":"11","key":"2358_CR85","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/S0032-9592(03)00053-0","volume":"38","author":"R Gupta","year":"2003","unstructured":"Gupta R, Gigras P, Mohapatra H, Goswami VK, Chauhan B. Microbial \u03b1-amylases: a biotechnological perspective. Process Biochem. 2003;38(11):1599\u2013616. https:\/\/doi.org\/10.1016\/S0032-9592(03)00053-0.","journal-title":"Process Biochem"},{"issue":"1","key":"2358_CR86","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0378-1119(82)90191-3","volume":"19","author":"I Palva","year":"1982","unstructured":"Palva I. Molecular cloning of alpha-amylase gene from Bacillus amyloliquefaciens and its expression in B. subtilis. Gene. 1982;19(1):81\u20137. https:\/\/doi.org\/10.1016\/0378-1119(82)90191-3.","journal-title":"Gene"},{"issue":"2","key":"2358_CR87","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0378-1119(89)90506-4","volume":"84","author":"N Tsukagoshi","year":"1989","unstructured":"Tsukagoshi N, Furukawa M, Nagaba H, Kirita N, Tsuboi A, Udaka S. Isolation of a cDNA encoding Aspergillus oryzae Taka-amylase a: evidence for multiple related genes. Gene. 1989;84(2):319\u201327. https:\/\/doi.org\/10.1016\/0378-1119(89)90506-4.","journal-title":"Gene"},{"issue":"12","key":"2358_CR88","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1093\/clinchem\/34.12.2463","volume":"34","author":"JL Rosenblum","year":"1988","unstructured":"Rosenblum JL. Direct, rapid assay of pancreatic isoamylase activity by use of monoclonal antibodies with low affinity for macroamylasemic complexes. Clin Chem. 1988;34(12):2463\u20138.","journal-title":"Clin Chem"},{"issue":"5","key":"2358_CR89","doi-asserted-by":"publisher","first-page":"e0154688","DOI":"10.1371\/journal.pone.0154688","volume":"11","author":"VB Doronin","year":"2016","unstructured":"Doronin VB, Parkhomenko TA, Castellazzi M, Cesnik E, Buneva VN, Granieri E, Nevinsky GA. Comparison of antibodies with amylase activity from cerebrospinal fluid and serum of patients with multiple sclerosis. PLoS ONE. 2016;11(5):e0154688. https:\/\/doi.org\/10.1371\/journal.pone.0154688.","journal-title":"PLoS ONE"},{"issue":"2","key":"2358_CR90","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1152\/physrev.1998.78.2.547","volume":"78","author":"KB Beckman","year":"1998","unstructured":"Beckman KB, Ames BN. The free radical theory of aging matures. Physiol Rev. 1998;78(2):547\u201381. https:\/\/doi.org\/10.1152\/physrev.1998.78.2.547.","journal-title":"Physiol Rev"},{"issue":"4\u20136","key":"2358_CR91","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0921-8734(93)90020-4","volume":"295","author":"RJ Feuers","year":"1993","unstructured":"Feuers RJ, Weindruch R, Hart RW. Caloric restriction, aging, and antioxidant enzymes. Mutat Res. 1993;295(4\u20136):191\u2013200. https:\/\/doi.org\/10.1016\/0921-8734(93)90020-4.","journal-title":"Mutat Res"},{"issue":"2","key":"2358_CR92","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/BF00421050","volume":"84","author":"D Harman","year":"1988","unstructured":"Harman D. Free radicals in aging. Mol Cell Biochem. 1988;84(2):155\u201361. https:\/\/doi.org\/10.1007\/BF00421050.","journal-title":"Mol Cell Biochem"},{"key":"2358_CR93","volume-title":"Oxidative stress: biochemical and pathophysiological aspects","author":"NK Zenkov","year":"2001","unstructured":"Zenkov NK, Lankin VZ, Men\u2019shchikova EB. Oxidative stress: biochemical and pathophysiological aspects. M.: MAIK Nauka. Interperiodica; 2001."},{"issue":"24","key":"2358_CR94","doi-asserted-by":"publisher","first-page":"9748","DOI":"10.1073\/pnas.85.24.9748","volume":"85","author":"B Frei","year":"1988","unstructured":"Frei B, Stocker R, Ames BN. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci U S A. 1988;85(24):9748\u201352. https:\/\/doi.org\/10.1073\/pnas.85.24.9748.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2358_CR95","doi-asserted-by":"publisher","first-page":"221","DOI":"10.4161\/mabs.2.3.11788","volume":"2","author":"IR Correia","year":"2010","unstructured":"Correia IR. Stability of IgG isotypes in serum. MAbs. 2010;2(3):221\u201332. https:\/\/doi.org\/10.4161\/mabs.2.3.11788.","journal-title":"MAbs"},{"issue":"1","key":"2358_CR96","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/jmr.923","volume":"22","author":"AS Tolmacheva","year":"2009","unstructured":"Tolmacheva AS, Zaksas NP, Buneva VN, Vasilenko NL, Nevinsky GA. Oxidoreductase activities of polyclonal IgGs from the sera of Wistar rats are better activated by combinations of different metal ions. J Mol Recognit. 2009;22(1):26\u201337. https:\/\/doi.org\/10.1002\/jmr.923.","journal-title":"J Mol Recognit"},{"key":"2358_CR97","first-page":"39","volume":"3","author":"AS Tolmacheva","year":"2009","unstructured":"Tolmacheva AS, Vasilenko NL, Zaksas NP, Sinitsina OI, Buneva VN, Nevinsky GA. Immunoglobulins a from the blood of healthy Wistar rats oxidize amines. Russ J Immunol. 2009;3:39\u201349.","journal-title":"Russ J Immunol"},{"issue":"9","key":"2358_CR98","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/jmr.2474","volume":"28","author":"AS Tolmacheva","year":"2015","unstructured":"Tolmacheva AS, Blinova EA, Ermakov EA, Buneva VN, Vasilenko NL, Nevinsky GA. IgG abzymes with peroxidase and oxidoreductase activities from the sera of healthy humans. J Mol Recognit. 2015;28(9):565\u201380. https:\/\/doi.org\/10.1002\/jmr.2474.","journal-title":"J Mol Recognit"},{"issue":"1","key":"2358_CR99","doi-asserted-by":"publisher","first-page":"171097","DOI":"10.1098\/rsos.171097","volume":"5","author":"AS Tolmacheva","year":"2018","unstructured":"Tolmacheva AS, Ermakov EA, Buneva VN, Nevinsky GA. Substrate specificity of healthy human sera IgG antibodies with peroxidase and oxydoreductase activities. R Soc Open Sci. 2018;5(1):171097. . https:\/\/doi.org\/10.1098\/rsos.171097","journal-title":"R Soc Open Sci"},{"issue":"12","key":"2358_CR100","doi-asserted-by":"publisher","first-page":"e2807","DOI":"10.1002\/jmr.2807","volume":"32","author":"AS Tolmacheva","year":"2019","unstructured":"Tolmacheva AS, Buneva VN, Nevinsky GA. Substrate specificity of IgGs with peroxidase and oxidoreductase activities from sera of patients with systemic lupus erythematosus and multiple sclerosis. J Mol Recognit. 2019;32(12):e2807. https:\/\/doi.org\/10.1002\/jmr.2807.","journal-title":"J Mol Recognit"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02358-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-026-02358-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02358-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T08:05:51Z","timestamp":1789373151000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-026-02358-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2358"],"URL":"https:\/\/doi.org\/10.1007\/s00011-026-02358-8","relation":{},"ISSN":["1420-908X"],"issn-type":[{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"assertion":[{"value":"4 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest. The funders had no role in the design of the study in the collection analyses or interpretation of data in the writing of the manuscript or in the decision to publish the results.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocols of all analysis were supported by the bioethical committee protocol \u2116201 of the Institute of Chemical Biology and Fundamental Medicine of SB RAS and the recommendations of the European Committee (Council Directive of European Communities135 86\/609\/CEE; document number 21\u2009\u2212\u20094 from 7 August 2020).","order":3,"name":"Ethics","label":"Institutional review board statement","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"210"}}